Topics
High-grade gliomas | Treatment | Targeted therapy | Bevacizumab
Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy > Bevacizumab
Liao Y, Bai X, Cao Y, Zhang
M.
Effect
of low-dose bevacizumab on health-related quality of life in
patients with recurrent high-grade glioma: A retrospective
clinical study.
J
Clin Neurosci.
2024 Jan 25;120:196-203. doi: 10.1016/j.jocn.2024.01.018? PMID:
38277995. Observational study. ˍ